Principia Biopharma, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: South San Francisco United States (2008)
Status: Acquired by Sanofi-Aventis (2020)

Organization Overview

First Clinical Trial
2015
NCT02608125
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Principia Biopharma | Principia Biopharma Australia Pty Ltd. | Principia Biopharma Inc. | Principia Biopharma, Inc.